PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cells engineered to produce immune-boosting amino acids in prizewinning research

2024-04-04
(Press-News.org) Bacterial proteins often play a successful hide and seek game with the body’s immune system, making it difficult to combat the bacteria that cause diseases like staph infections.

 

Now, biomolecular engineer Aditya Kunjapur and colleagues have come up with a strategy to create bacteria that build and incorporate a key amino acid into their own proteins, which makes the proteins more “visible” to the immune system.

 

For this work toward building a better platform for possible future bacterial vaccines, Kunjapur is the winner of the 2024 BioInnovation Institute & Science Prize for Innovation. The prize seeks to reward scientists who deliver research at the intersection of the life sciences and entrepreneurship.

 

“Dr. Kunjapur's outstanding research demonstrates the potential to engineer live bacterial cells to produce and incorporate nitrated amino acids into antigenic proteins, thus shining a spotlight on these proteins for the human immune system,” said Michael Funk, senior editor at Science. “This work provides a platform for antigen engineering that is adaptable, specific, and amenable to safety controls.”

 

In his winning essay published April 5 in Science, Kunjapur, an assistant professor of chemical and biomolecular engineering at the University of Delaware, writes that “our primary hypothesis is that engineering cells to access a broader chemical repertoire of building blocks can improve live bacterial vaccine efficacy.”

 

One of the building blocks that caught Kunjapur’s eye came from previous research that modified a bacterial protein with a non-standard amino acid called para-nitro-L-phenylalanine (nitro-Phe). These nitrated proteins triggered sustained production of antibodies in mice, suggesting that the altered amino acid was making the bacterial protein easier to access or easier to recognize by the immune system.

 

Kunjapur and colleagues have now programmed E. coli bacterial cells to synthesize their own nitro-Phe and incorporate it into target proteins. These altered proteins could someday become the basis for a live bacterial vaccine, the researchers suggest.

 

“In principle, the nitro-Phe modified protein produced by the engineered bacteria within a patient would lead to a targeted, sustained, and protective immune response towards bacterial pathogens that contain the wildtype form of the protein,” Kunjapur writes.

 

Kunjapur’s research team used E. coli as a proof-of-concept for their bioengineering strategy, but he said the strategy could work with other bacteria as well, including those that might be better at targeting certain pathogens or even tumor tissue.

 

“We could also continue to use E. coli as a platform vector that makes recombinant proteins that belong to other bacteria,” he said. “So you can pick your chassis or your protein delivery vehicle, but the proteins you choose to nitrate should determine what immune cells respond to.”

 

“While we have a platform technology with several promising directions, one attractive indication would be a vaccine for staph infections,” Kunjapur added. The need for a staph vaccine was emphasized in meetings Kunjapur’s postdoc Neil Butler held with individuals from pharmaceutical companies, clinical trial operators, and hospital staff as part of his participation with the U.S. National Science Foundation Innovation Corps program.

 

Vaccines against bacterial infections would likely decrease the need for antibiotic medicines, which in turn could stem the development of antibiotic resistance in some key drugs. Kunjapur said bacterial vaccines have an estimated global market size of $39.6 billion by 2030.

 

Finding funding for filing intellectual property was a challenge during the years of the pandemic, and Kunjapur used his own funds for his Patent Cooperation Treaty patent application. “At the time I had cautious optimism in investing in new potential vaccine modalities during the height of a pandemic, but a lot of it was also a bet on the people behind the idea and our collaborators,” he said.

 

Kunjapur co-founded Nitro Biosciences, Inc. with Butler to pursue the nitro-Phe technology. He said starting the company has made him think more about who is going to use the technology, and what kind of criteria and metrics they need to know so that it can be used successfully.

 

“It’s a shame that a lot of academic work has the potential to make a difference in people’s lives, but academics aren’t ordinarily incentivized or trained to think about what the customer needs, who the customer is, and how do you advance the technology to the stage where it could be in the clinic,” Kunjapur said.

 

In his lab at the University of Delaware, Kunjapur and his students are also working on other bioengineering projects with environmental applications, including containment strategies “to prevent a genetically modified organism like bacteria from surviving where and when it shouldn’t.”

 

“This year’s finalists have conducted some truly exceptional research and the standard of all entries was extremely high,” said Jens Nielsen, chief executive officer at BioInnovation Institute. “Their work combines cutting edge science with entrepreneurial spirit, aligning with BII’s goals of improving human and planetary health.”

 

FINALISTS

 

William Wasswa is a 2024 finalist for his essay, “Automated innovation and impact. Wasswa received a bachelor’s degree from Mbarara University of Science and Technology (MUST), a master’s degree from the University of Cape Town, and a Ph.D. from MUST, where he spent some time at the University of Strathclyde, UK under the Commonwealth Ph.D. split-site scholarships. He completed his postdoctoral fellowship under the AfyaBora Global Health Leadership Fellowship program and an Innovations & Entrepreneurship Fellowship from the Royal Academy of Engineering. In 2020, he started his Medical Imaging and Artificial Intelligence Laboratory in the Department of Biomedical Sciences and Engineering at MUST and a Digital Health Unit at Global Auto Systems LTD. His research and innovation work is focused on the development of low-cost digital technologies to support the diagnosis, treatment and management of cancer in Africa.

 

Khalil Ramadi is a finalist for his essay, “Edible electronics to treat the brain.” Ramadi received an undergraduate degree from Pennsylvania State University and a PhD from the Massachusetts Institute of Technology. After completing his postdoctoral fellowship at Brigham and Women’s Hospital, Ramadi started his laboratory in the bioengineering department at New York University Abu Dhabi in 2020. His research focuses on developing neurotechnologies for improved therapy of neurologic, metabolic, and immune disorders.

END


ELSE PRESS RELEASES FROM THIS DATE:

Flexible fiber, coupled to the human body, enables chipless textile electronics

2024-04-04
A flexible electronic fiber that utilizes the human body as part of the circuit enables textile-based electronics without the need for batteries or chips, researchers report. According to the authors, the approach is well-suited for scalable manufacture of comfortable fiber-based electronics for a wide range of applications, including “smart” clothing. Textile electronic systems are designed to equip textile or fiber assemblies with electronic functions for sensing, computation, display, or communication. They create vast opportunities ranging from physiological monitoring to powering ...

Governance frameworks should address the prospect of AI systems that cannot be safely tested

2024-04-04
In this Policy Forum, Michael Cohen and colleagues highlight the unique risks presented by a particular class of artificial intelligence (AI) systems: reinforcement learning (RL) agents that plan more effectively than humans over long horizons. “Giving [such] an advanced AI system the objective to maximize its reward and, at some point, withholding reward from it, strongly incentivizes the AI system to take humans out of the loop,” write Cohen and colleagues. This incentive also arises for long-term planning agents (LTPAs) more generally, say the authors, and in ways empirical testing is unlikely to cover. It is thus critical to address extinction risk from these ...

Revealed: Mechanical damage during an asthma attack

2024-04-04
In asthma, the tightening of muscles around the bronchi causes damage to the airway by squeezing and destroying epithelial cells, which promotes the airway inflammation and mucus production often associated with an asthma attack, researchers report. The findings suggest that preventing the mechanical damage caused by an asthma attack, rather than treating only its downstream symptoms, could pave the way for therapies that stop the whole asthma inflammatory cycle. Asthma is a common airway disorder affecting more than 300 million people worldwide. Although it is primarily considered an inflammatory disease, a diagnostic feature of asthma is mechanical bronchoconstriction – the ...

Agricultural diversification yields joint environmental and social benefits

2024-04-04
Promoting livestock biodiversity and soil conservation strategies provides both social and environmental benefits, according to a new study. The findings suggest that well-designed polices aimed at incentivizing the adoption of multiple diversification strategies could mitigate simplified agriculture’s negative environmental, health, and social impacts. “Our interdisciplinary analysis spanning a wide array of regions provides convincing evidence that agricultural diversification is a promising win-win strategy for providing social and environmental benefits,” write the authors. Agricultural lands tend to be simplified ecosystems designed ...

Nerve cells not entirely “young at heart”

Nerve cells not entirely “young at heart”
2024-04-04
After two decades in the United States, Martin Hetzer returned home to Austria in 2023 to become the 2nd President of the Institute of Science and Technology Austria (ISTA). A year into his new role, the molecular biologist remains engaged in the realm of aging research. Hetzer is fascinated by the biological puzzles surrounding the aging processes in organs like the brain, heart, and pancreas. Most cells comprising these organs are not renewed throughout a human’s entire life span. Nerve cells (neurons) in the human brain, for instance, can be as old as the organism, even ...

Discovery of how limiting damage from an asthma attack could stop disease

2024-04-04
Scientists at King’s College London have discovered a new cause for asthma that sparks hope for treatment that could prevent the life-threatening disease. Most current asthma treatments stem from the idea that it is an inflammatory disease. Yet, the life-threatening feature of asthma is the attack or the constriction of airways, making breathing difficult. The new study, published today in Science, shows for the first time that many features of an asthma attack—inflammation, mucus secretion, and damage to the airway barrier that ...

Less extensive breast cancer surgery results in fewer swollen arms

2024-04-04
 It is possible to leave most of the lymph nodes in the armpit, even if one or two of them have metastases larger than two millimetres? This is shown in a trial enrolling women from five countries, led by researchers at Karolinska Institutet and published in the New England Journal of Medicine. The results open up for gentler surgery for patients with breast cancer.  Breast cancer can spread to the lymph nodes in the armpit. However, tumours found only in the breast and armpit lymph nodes are considered a localized disease, with the goal of curing the patient.  A challenging question for breast cancer surgeons revolves around what should ...

Body mapping links our responses to music with their degree of uncertainty and surprise

Body mapping links our responses to music with their degree of uncertainty and surprise
2024-04-04
Music holds an important place in human culture, and we’ve all felt the swell of emotion that music can inspire unlike almost anything else. But what is it exactly about music that can bring on such intense sensations in our minds and bodies? A new study reported in the journal iScience on April 4 has insight from studies that systematically examine the way perception of unique musical chords elicits specific bodily sensations and emotions. “This study reveals the intricate interplay between musical uncertainty, prediction ...

Shaking tiny clusters of brain cells, scientists reveal an overlooked protein’s role in traumatic brain injury

Shaking tiny clusters of brain cells, scientists reveal an overlooked protein’s role in traumatic brain injury
2024-04-04
Clinicians often find limited success in treating patients with traumatic brain injury, a condition long linked to contact sports and military services. A new study, published April 4 in the journal Cell Stem Cell, may offer new clues to better solutions. Scientists found a protein, TDP-43, that appears to drive nerve damage right after injury. Moreover, blocking a certain cell surface protein can correct faulty TDP-43 and curb nerve death in mouse and human cells. “There’s really nothing out there that can prevent the injury ...

Mistreatment in childbirth is common in the US especially among the disadvantaged

2024-04-04
Lack of respectful maternity care in the U.S. culminating in mistreatment in childbirth is a regular occurrence, according to a new study at Columbia University Mailman School of Public Health. Yet until now experiences of this mistreatment had not been widely documented in the United States.  The findings are published in JAMA Network Open. To estimate the prevalence of mistreatment by care providers in childbirth, the researchers collected survey data from a representative sample of people who had a live birth in 2020 ...

LAST 30 PRESS RELEASES:

Cellular traffic congestion in chronic diseases suggests new therapeutic targets

Cervical cancer mortality among US women younger than age 25

Fossil dung reveals clues to dinosaur success story

New research points way to more reliable brain studies

‘Alzheimer’s in dish’ model shows promise for accelerating drug discovery

Ultraprocessed food intake and psoriasis

Race and ethnicity, gender, and promotion of physicians in academic medicine

Testing and masking policies and hospital-onset respiratory viral infections

A matter of life and death

Huge cost savings from more efficient use of CDK4/6 inhibitors in metastatic breast cancer reported in SONIA study

What a gut fungus reveals about symbiosis and allergy

Insilico Medicine recognized by Endeavor Venture Group & Mount Sinai Health System with Showcase AI and Biotech Innovation Award

ESMO Asia Congress 2024: Event Announcement

The pathophysiological relationship and treatment progress of obstructive sleep apnea syndrome, obesity, and metabolic syndrome

“Genetic time machine” reveals complex chimpanzee cultures

Earning money while making the power grid more stable – energy consumers have a key role in supporting grid flexibility

No ‘one size fits all’ treatment for Type 1 Diabetes, study finds

New insights into low-temperature densification of ceria-based barrier layers for solid oxide cells

AI Safety Institute launched as Korea’s AI Research Hub

Air pollution linked to longer duration of long-COVID symptoms

Soccer heading damages brain regions affected in CTE

Autism and neural dynamic range: insights into slower, more detailed processing

AI can predict study results better than human experts

Brain stimulation effectiveness tied to learning ability, not age

Making a difference: Efficient water harvesting from air possible

World’s most common heart valve disease linked to insulin resistance in large national study

Study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system

Long-sought structure of powerful anticancer natural product solved by integrated approach

World’s oldest lizard wins fossil fight

Simple secret to living a longer life

[Press-News.org] Cells engineered to produce immune-boosting amino acids in prizewinning research